✦ LIBER ✦

A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer

✍ Scribed by Pronzato, P; Bertelli, G; Vigani, A; Vaira, F

Book ID: 109837254
Publisher: Nature Publishing Group
Year: 1996
Tongue: English
Weight: 533 KB
Volume: 73
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1996.270

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison of cisplatin and the combin

A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A national bladder cancer collaborative group a study

✍ Mark S. Soloway; Albert Einstein; Michael P. Corder; William Bonney; George R. P 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

A randomized trial of cyclophosphamide a

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study

✍ George Omura; John A. Blessing; Clarence E. Ehrlich; Alexander Miller; Edgardo Y 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

Treatment of advanced ovarian cancer: A

Treatment of advanced ovarian cancer: A randomised trial comparing adriamycin or 4′epi-adriamycin in combination with cisplatin and cyclophosphamide

✍ Bezwoda, W. R. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'

A feasibility study of 252Cf neutron bra

A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer

✍ Yosh Maruyama; Mary G. Bowen; John R. Van Nagell; Holly H. Gallion; Paul Depries 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 760 KB

Cisplatin and escalating doses of paclit

Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study

✍ Mario Nardi; Salvatore De Marco; Alessandra Fabi; Alessandra Aloe; Elena Magnani 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 70 KB

Erythropoietin and granulocyte-macrophag

Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer

✍ M. Venturini; L. Del Mastro; Franco Testore; Marco Danova; Ornella Garrone; Clau 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 160 KB